DEA Approves Study of Cannabis in Treating PTSD

ptsdThe Drug Enforcement Agency (DEA) has given approval to a study examining the benefits of cannabis in treating post traumatic stress disorder (PTSD).

According to the Multidisciplinary Association for Psychedelic Studies (MAPS), who will be conducting the study, the DEA has given them approval to purchase whole-plant cannabis from the National Institute of Drug Abuse, the only federal agency that can distribute cannabis for research purposes. Now that MAPS has this approval, they’ll now begin the process of recruiting and enrolling study participants.

Read moreDEA Approves Study of Cannabis in Treating PTSD

U.S. House Votes to Prevent Government from Interfering with State Medical Cannabis Laws

usWith a 242 to 186 vote, the United States House of Representatives has approved an amendment to a federal spending bill that would prevent the federal government from interfering with state-sanctioned medical cannabis programs.

The amendment, introduced by Representatives Dana Rohrabacher (R-CA) and Sam Farr (D-CA), was added to the Commerce, Justice, Science and Related Agencies Appropriations Act. It explicitly prohibits the Department of Justice, which includes the Drug Enforcement Administration (DEA), from using any funding to interfere in the implementation of laws legalizing medical cannabis at the state-level.

Read moreU.S. House Votes to Prevent Government from Interfering with State Medical Cannabis Laws

FDA Evaluating Cannabis for Potential Rescheduling

The U.S. Food and Drug Administration (FDA) is reviewing the evidence surrounding the safety and effectiveness of cannabisfda as a medicine in an attempt to determine whether its status as a Schedule 1 drug – which puts it alongside hard drugs such as heroin – is unwarranted, and should be changed.

“FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration, which is currently ongoing,” FDA Press Officer Jeff Ventura told the Huffington Post. “HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule.”

Read moreFDA Evaluating Cannabis for Potential Rescheduling

DEA Settles Suit Alleging Lie-Detector Abuses

By Marisa Taylor, McClatchy DC

The Drug Enforcement Administration has agreed to pay 14 contractors $500,000 to settle a lawsuit that accuses the agency of illegally requiringlie them to undergo highly intrusive lie detector tests to keep their jobs as translators.

The settlement appears to be the first time that a federal government agency has settled allegations involving contractors’ lie detector tests since a 1988 law banned the use of polygraph screening for most private employees, said a lawyer for the group.

Read moreDEA Settles Suit Alleging Lie-Detector Abuses

DEA to Release 250 Pounds of Hemp Seeds to Kentucky After Agriculture Commissioner Files Lawsuit

Kentucky Agriculture Commissioner James Comer has been planning hemp pilot projects around the state designed to research various aspects of industrial hemphemp-seeds. Given the federal government recently legalized hemp research in states that have done the same (Kentucky legalized hemp last year), these projects are entirely legal. However, despite the legality of what Comer has planned, the DEA recently put a block on a 250-pound shipment of hemp seeds being sent from Italy, to Kentucky. Now, just days after blocking the shipment, the DEA has backed down and will be releasing the seeds.

Read moreDEA to Release 250 Pounds of Hemp Seeds to Kentucky After Agriculture Commissioner Files Lawsuit